Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.24
ATEC's Cash to Debt is ranked higher than
53% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.04 vs. ATEC: 0.24 )
ATEC' s 10-Year Cash to Debt Range
Min: 0.23   Max: No Debt
Current: 0.24

Equity to Asset 0.43
ATEC's Equity to Asset is ranked higher than
58% of the 301 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. ATEC: 0.43 )
ATEC' s 10-Year Equity to Asset Range
Min: -0.18   Max: 0.71
Current: 0.43

-0.18
0.71
Interest Coverage 0.14
ATEC's Interest Coverage is ranked lower than
59% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.94 vs. ATEC: 0.14 )
ATEC' s 10-Year Interest Coverage Range
Min: 0.14   Max: 9999.99
Current: 0.14

0.14
9999.99
F-Score: 4
Z-Score: 0.22
M-Score: -2.49
WACC vs ROIC
14.72%
2.17%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) 0.89
ATEC's Operating margin (%) is ranked higher than
65% of the 308 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.92 vs. ATEC: 0.89 )
ATEC' s 10-Year Operating margin (%) Range
Min: -35.87   Max: 1.98
Current: 0.89

-35.87
1.98
Net-margin (%) -6.22
ATEC's Net-margin (%) is ranked higher than
61% of the 308 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.28 vs. ATEC: -6.22 )
ATEC' s 10-Year Net-margin (%) Range
Min: -40.16   Max: 2.86
Current: -6.22

-40.16
2.86
ROE (%) -8.01
ATEC's ROE (%) is ranked higher than
60% of the 297 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.57 vs. ATEC: -8.01 )
ATEC' s 10-Year ROE (%) Range
Min: -92.63   Max: 55.69
Current: -8.01

-92.63
55.69
ROA (%) -3.56
ATEC's ROA (%) is ranked higher than
62% of the 311 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.93 vs. ATEC: -3.56 )
ATEC' s 10-Year ROA (%) Range
Min: -23.56   Max: 9
Current: -3.56

-23.56
9
ROC (Joel Greenblatt) (%) 3.27
ATEC's ROC (Joel Greenblatt) (%) is ranked higher than
67% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.68 vs. ATEC: 3.27 )
ATEC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -135.68   Max: 5.95
Current: 3.27

-135.68
5.95
Revenue Growth (3Y)(%) -1.70
ATEC's Revenue Growth (3Y)(%) is ranked higher than
62% of the 263 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.60 vs. ATEC: -1.70 )
ATEC' s 10-Year Revenue Growth (3Y)(%) Range
Min: -3.8   Max: 32.5
Current: -1.7

-3.8
32.5
EPS Growth (3Y)(%) -19.60
ATEC's EPS Growth (3Y)(%) is ranked higher than
57% of the 228 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.40 vs. ATEC: -19.60 )
ATEC' s 10-Year EPS Growth (3Y)(%) Range
Min: -37   Max: 128.9
Current: -19.6

-37
128.9
» ATEC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

ATEC Guru Trades in Q1 2014

Jim Simons 147,100 sh (+152.32%)
» More
Q2 2014

ATEC Guru Trades in Q2 2014

George Soros 35,816 sh (New)
Jim Simons 322,500 sh (+119.24%)
» More
Q3 2014

ATEC Guru Trades in Q3 2014

George Soros Sold Out
Jim Simons 256,300 sh (-20.53%)
» More
Q4 2014

ATEC Guru Trades in Q4 2014

Jim Simons 283,200 sh (+10.50%)
» More
» Details

Insider Trades

Latest Guru Trades with ATEC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 1.00
ATEC's P/B is ranked higher than
96% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.00 vs. ATEC: 1.00 )
ATEC' s 10-Year P/B Range
Min: 0.58   Max: 3.79
Current: 1

0.58
3.79
P/S 0.68
ATEC's P/S is ranked higher than
95% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.17 vs. ATEC: 0.68 )
ATEC' s 10-Year P/S Range
Min: 0.49   Max: 2.88
Current: 0.68

0.49
2.88
EV-to-EBIT 112.66
ATEC's EV-to-EBIT is ranked higher than
69% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 35.16 vs. ATEC: 112.66 )
ATEC' s 10-Year EV-to-EBIT Range
Min: -56.3   Max: 116.4
Current: 112.66

-56.3
116.4
Current Ratio 1.78
ATEC's Current Ratio is ranked higher than
60% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.61 vs. ATEC: 1.78 )
ATEC' s 10-Year Current Ratio Range
Min: 1.11   Max: 2.82
Current: 1.78

1.11
2.82
Quick Ratio 1.12
ATEC's Quick Ratio is ranked higher than
58% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.77 vs. ATEC: 1.12 )
ATEC' s 10-Year Quick Ratio Range
Min: 0.71   Max: 1.82
Current: 1.12

0.71
1.82
Days Inventory 241.91
ATEC's Days Inventory is ranked higher than
57% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 134.93 vs. ATEC: 241.91 )
ATEC' s 10-Year Days Inventory Range
Min: 87.41   Max: 251.9
Current: 241.91

87.41
251.9
Days Sales Outstanding 71.31
ATEC's Days Sales Outstanding is ranked higher than
70% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 70.73 vs. ATEC: 71.31 )
ATEC' s 10-Year Days Sales Outstanding Range
Min: 52.2   Max: 84.6
Current: 71.31

52.2
84.6

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.60
ATEC's Price/Median PS Value is ranked higher than
96% of the 341 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. ATEC: 0.60 )
ATEC' s 10-Year Price/Median PS Value Range
Min: 0.6   Max: 2.1
Current: 0.6

0.6
2.1
Earnings Yield (Greenblatt) 0.90
ATEC's Earnings Yield (Greenblatt) is ranked higher than
61% of the 304 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.40 vs. ATEC: 0.90 )
ATEC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.9   Max: 1
Current: 0.9

0.9
1

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Alphatec Holdings, Inc. was incorporated on March 4, 2005. The Company is a medical technology company, which is engaged in the design, development, manufacturing, and marketing of products for the surgical treatment of spine disorders, with a focus on products that treat conditions that affect the aging spine. The Company's product portfolio and pipeline includes a number of spinal disorder products and systems focused on solutions addressing the cervical, thoracolumbar, intervertebral, minimally invasive, vertebral compression fracture, osteoporotic bone, and spinal stenosis markets. Its main product offerings are focused on the market for orthopedic spinal disorder solution products. The Company also sells allograft spacers available in different shapes and sizes, each with corresponding instrumentation, which are intended for use in the cervical, thoracic, and lumbar regions of the spine. The Company operates an in-house manufacturing facility that enables it to deliver solutions to meet surgeons' and patients' needs. In addition to selling its products in the U.S., the Company also sells its products in Japan, the European Union and Hong Kong. It conducts its manufacturing operations at its facilities in Carlsbad, California. Its products and systems are made of titanium, titanium alloy, stainless steel and a strong, heat resistant, radiolucent, biocompatible plastic called polyetheretherketone, or PEEK. It sells its products directly to distributors, and its distributors resell its products to hospitals. The competitors of Company are Medtronic Sofamor Danek, Johnson & Johnson (DePuy/Synthes), Stryker, Biomet, NuVasive, Zimmer, Orthofix, Globus Medical, Integra Life Science, LDR Spine and others. The Company's products are subject to extensive regulation by the FDA and other U.S. federal and state regulatory bodies and comparable authorities in other countries.
» More Articles for ATEC

Headlines

Articles On GuruFocus.com
Weekly CEO Buys Highlight: TDY, GDI, ATEC, PBCT, SPAR Mar 18 2012 
Alphatec Holdings Inc. Reports Operating Results (10-Q) Nov 08 2010 
Alphatec Holdings Inc. (ATEC) CEO Dirk Kuyper buys 23,000 Shares Aug 27 2010 
Alphatec Holdings Inc. Reports Operating Results (10-Q) May 10 2010 
Alphatec Spine Announces Second Quarter 2009 Revenue and Financial Results Aug 03 2009 
Alphatec Holdings Inc. (ATEC) CFO Peter C Wulff buys 4,500 Shares Mar 10 2009 
Alphatec Spine Reports Preliminary Fourth Quarter and Full-Year 2008 Revenues; Provides 2009 Revenue Jan 13 2009 
Alphatec Spine to Hold 2009 Revenue and Earnings Guidance Investor Call Jan 09 2009 

More From Other Websites
Alphatec Spine to Release First Quarter 2015 Financial Results Apr 17 2015
Alphatec Spine to Release First Quarter 2015 Financial Results Apr 17 2015
Alphatec Spine to Present at 10th Annual Canaccord Genuity Musculoskeletal Conference Mar 10 2015
Alphatec Spine to Present at 10th Annual Canaccord Genuity Musculoskeletal Conference Mar 10 2015
ALPHATEC HOLDINGS, INC. Financials Mar 07 2015
Alphatec Holdings Announces Fourth Quarter and Full Year 2014 Revenue and Financial Results Mar 04 2015
10-K for Alphatec Holdings, Inc. Mar 02 2015
ALPHATEC HOLDINGS, INC. Files SEC form 10-K, Annual Report Feb 27 2015
Alphatec posts 4Q loss Feb 26 2015
Alphatec posts 4Q loss Feb 26 2015
ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in... Feb 26 2015
Alphatec Holdings Inc Earnings Call scheduled for 5:00 pm ET today Feb 26 2015
Alphatec Holdings Announces Fourth Quarter and Full Year 2014 Revenue and Financial Results Feb 26 2015
Q4 2014 Alphatec Holdings Inc Earnings Release - After Market Close Feb 26 2015
Alphatec Spine to Present at 35th Annual Cowen and Company Healthcare Conference Feb 18 2015
Alphatec Spine to Present at 35th Annual Cowen and Company Healthcare Conference Feb 18 2015
Alphatec Spine to Release Fourth Quarter and Fiscal Year 2014 Financial Results Feb 05 2015
ALPHATEC HOLDINGS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities Dec 29 2014
Alphatec Spine to Present at Upcoming Investor Events in December 2014 Nov 25 2014
Alphatec Spine Announces Appointment of Tom C. Davis to Its Board of Directors Nov 24 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK